Federica Barzaghi

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Busulfan exposure variability and acute toxicity in pediatric patients undergoing hematopoietic stem cell gene therapy.

Busulfan exposure variability and acute toxicity in pediatric patients undergoing hematopoietic stem cell gene therapy.

Journal: Frontiers in pharmacology

Published: May 04, 2026

Pregnancy and lactation during anifrolumab treatment in systemic lupus erythematosus.

Pregnancy and lactation during anifrolumab treatment in systemic lupus erythematosus.

Journal: Dermatology reports

Published: April 22, 2026

Gene therapy supports long-term reconstitution of patient hematopoietic stem cells in deficiency of adenosine deaminase 2.

Gene therapy supports long-term reconstitution of patient hematopoietic stem cells in deficiency of adenosine deaminase 2.

Journal: Molecular therapy. Methods & clinical development

Published: September 16, 2025

Uncommon causal variants of the ADA2 gene in patients with reduced enzyme activity and nonconfirmatory genetic testing.

Uncommon causal variants of the ADA2 gene in patients with reduced enzyme activity and nonconfirmatory genetic testing.

Journal: The journal of allergy and clinical immunology. In practice

Published: July 27, 2025

Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy.

Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy.

Journal: The New England journal of medicine

Published: April 23, 2025

Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function.

Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function.

Journal: Nature immunology

Published: December 16, 2024

One hundred thirty-four germ line PU.1 variants and the agammaglobulinemic patients carrying them.

One hundred thirty-four germ line PU.1 variants and the agammaglobulinemic patients carrying them.

Journal: Blood

Published: September 09, 2024

Report of the Italian Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome in the Target Therapy Era.

Report of the Italian Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome in the Target Therapy Era.

Journal: Journal of clinical immunology

Published: August 12, 2024

Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for diagnosing inborn errors of immunity.

Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for diagnosing inborn errors of immunity.

Journal: The Journal of allergy and clinical immunology

Published: July 22, 2024

Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities.

Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities.

Journal: The Journal of allergy and clinical immunology

Published: May 06, 2024

Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome.

Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome.

Journal: Science translational medicine

Published: May 01, 2024

Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERK-mediated monocyte activation.

Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERK-mediated monocyte activation.

Journal: The Journal of clinical investigation

Published: April 02, 2024

Showing 1-12 of 82

Last Updated: 09/26/2026